Inhaled nitric oxide and vasoconstrictors in acute respiratory distress syndrome.

Papazian, L; Roch, A; Bregeon, F; Thirion, X; Gaillat, F; Saux, P; Fulachier, V; Jammes, Y; Auffray, J P

Papazian, L; Roch, A; Bregeon, F; Thirion, X; Gaillat, F; Saux, P; Fulachier, V; Jammes, Y; Auffray, J P.

Affiliation

Papazian L; Service de Réanimation, Service d'Information Médicale, Hôpital Sainte-Marguerite, Marseille, France.

Am J Respir Crit Care Med ; 160(2): 473-9, 1999 Aug.

Article in En | MEDLINE | ID: mdl-10430716

Subject(s)

Almitrine/administration & dosage; Nitric Oxide/administration & dosage; Norepinephrine/administration & dosage; Respiratory Distress Syndrome/drug therapy; Vasoconstrictor Agents/administration & dosage; Administration, Inhalation; Adult; Aged; Aged, 80 and over; Almitrine/adverse effects; Critical Care; Drug Synergism; Drug Therapy, Combination; Female; Hemodynamics/drug effects; Humans; Male; Middle Aged; Nitric Oxide/adverse effects; Norepinephrine/adverse effects; Oxygen/blood; Pulmonary Wedge Pressure/drug effects; Respiratory Function Tests; Vasoconstrictor Agents/adverse effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Respiratory Distress Syndrome / Vasoconstrictor Agents / Norepinephrine / Almitrine / Nitric Oxide Type of study: Clinical_trials Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 1999 Document type: Article Affiliation country: France Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links